Last updated on November 2017

Clinical trial for People with Chronic Lymphocytic Leukemia (CLL)


Brief description of study

Clinical trial for People with Chronic Lymphocytic Leukemia (CLL)

Detailed Study Description

This clinical trial is provided by TrialReach.

People with Chronic Lymphocytic Leukemia (CLL) often require combinations of different therapies to treat their CLL. The drug obinutuzumab combined with the chemotherapy drug chlorambucil is an approved therapy for the treatment of CLL, however it may not be effective for all patients. The combination of two investigational drugs, Ublituximab and TGR-1202, may be effective as a new treatment for CLL. This study is evaluating whether the new combination results in better outcomes for patients with CLL, inclu

Clinical Study Identifier: TX10242

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )